S-4 Filing

Aimfinity in October signed a $60 million merger agreement with Docter Inc., a Taiwanese non-invasive blood glucose watch developer.

The SPAC last month announced a merger agreement with Car Tech, a U.S. stamped auto-body parts manufacturer and subsidiary of Korean supplier, Shinyoung Co.

The target is a global solutions provider for the high-tech electronic, photovoltaics, glass, and energy systems industries.

Arrowroot has postponed a shareholder vote on the deal five times. The vote is currently slated for April 1.

Fintech Ecosystem has a pending deal with Mobitech International (dba Afinoz), at an implied $120 million enterprise value.

Founded in 2020, the target is engaged in the development, production and sales of personal care products and other consumer goods in China.

The SPAC last August announced a merger with Cardea Capital, a global wealth management firm, at an implied pro-forma enterprise valuation of approximately $175 million.

Generation Asia I raised $200 million in a January 2022 IPO and has not yet announced a deal. The TMT-focused SPAC has been targeting companies across Asia, excluding China, Hong Kong and Macau.

The SPAC has a merger agreement with Bestpath, which develops hydrogen fuel cell powered vehicles in China.

The transaction has a minimum $350 million cash closing condition, net of transaction fees.